Skip Ribbon Commands
Skip to main content

Advanced TACE

​Taking TACE to the next level

​Our ultimate goal by taking TACE to the next level: to Prolong HCC patients Life expectancy.

Improving complete response rates and maintaining this response lead to an increase in overall survival1:

  • DEM-TACE treatments reach high complete response rates1
  • 60.1% Complete response rate leading to over 4 years overall survival (50.8month) (n=580 patients)1
  • Even when multiple treatments are required for larger, complex tumours2
  • 20% of patients achieved complete response after 3rd or 4th TACE procedures (n=97)2​

References

  1. ​​​Veloso Gomes et al Cardiovasc Intervent Radiol 2023 (Pooled analysis)​
  2. de Baere T et al. Cancers (Basel) 2020;12:E3405 (PARIS registry)​

Breaking new data with Advanced TACE

Watch the videos below - which are of presentations from ECIO 2021.

What the evidence says

Discover our clinical evidence and case studies concerning this topic.

Transarterial chemoembolization with anthracyclines-loaded polyethylene glycol drug eluting microspheres for the treatment of hepatocellular carcinoma: A pooled multicentric analysis of survival in 580 patients

Featured product: LifePearl™ Drug Elutable Microspheres

Balloon-Occluded Transarterial Chemoembolization: In which size range does it perform best? A comparison of its efficacy versus conventional Transarterial Chemoembolization, using Propensity score matching

Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter

Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study

Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter

Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results

Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter

Balloon-occluded chemoembolization for hepatocellular carcinoma: a prospective study of safety, feasibility and outcomes

Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter

Retrospective European Multicentric Evaluation of Selective Transarterial Chemoembolisation with and without Balloon-Occlusion in Patients with Hepatocellular Carcinoma: A Propensity Score Matched Analysis

Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter

Chemoembolization of Hepatocellular Carcinoma with Drug-Eluting Polyethylene Glycol Embolic Agents: Single-Center Retrospective Analysis in 302 Patients

Featured product: LifePearl™ Drug Elutable Microspheres

Chemoembolization Alone or Associated with Bevacizumab for Therapy of Colorectal Cancer Metastases: Preliminary Results of a Randomized Study

Featured product: LifePearl™ Drug Elutable Microspheres

LifePearl microspheres loaded with irinotecan in the treatment of Liver-dominant metastatic colorectal carcinoma: feasibility, safety and pharmacokinetic study

Featured product: LifePearl™ Drug Elutable Microspheres

Polyethylene Glycol Epirubicin-Loaded Transcatheter Arterial Chemoembolization Procedures Utilizing a Combined Approach with 100 and 200 μm Microspheres: A Promising Alternative to Current Standards

Featured product: LifePearl™ Drug Elutable Microspheres

Polyethylene glycol microspheres loaded with irinotecan for arterially directed embolic therapy of metastatic liver cancer

Featured product: LifePearl™ Drug Elutable Microspheres

Real Life Prospective Evaluation of New Drug-Eluting Platform for Chemoembolization of Patients with Hepatocellular Carcinoma: PARIS Registry

Featured product: LifePearl™ Drug Elutable Microspheres

Safety, tolerability, and efficacy of transarterial chemoembolization using anthracyclines-loaded drug-eluting microspheres for treatment of patients with unresectable hepatocellular carcinoma: Pooled analyses

Featured product: LifePearl™ Drug Elutable Microspheres

The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolization in Colorectal Cancer Liver Metastases: Interim Analysis

Featured product: LifePearl™ Drug Elutable Microspheres

Advanced TACE Programme Studies

Featured products: LifePearl™ Drug Elutable Microspheres, Occlusafe™ Temporary Occlusion Balloon Microcatheter

Balloon-Occluded Transcatheter Arterial Chemoembolization (b- TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results

Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter

Microballoon-related interventions in various endovascular treatments of body trunk lesions

Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter

Initial Experience with Balloon-Occluded Trans-catheter Arterial Chemoembolization (B-TACE) for Hepatocellular Carcinoma

Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter

Comparison of the Local Control Effects of Microballoon-Occluded Transarterial Chemoembolization (TACE) Using Miriplatin and Using Epirubicin for Hepatocellular Carcinoma: A Retrospective Study of 62 Cases

Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter

Hemodynamic Changes on Cone-Beam Computed Tomography during Balloon-Occluded Transcatheter Arterial Chemoembolization Using Miriplatin for Hepatocellular Carcinoma: A Preliminary Study

Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter

Selective balloon-occluded transarterial chemoembolization for patients with one or two hepatocellular carcinoma nodules: Retrospective comparison with conventional super-selective TACE

Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter

Balloon-occluded arterial stump pressure before balloon-occluded transarterial chemoembolization

Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter

Efficacy of a microballoon catheter in transarterial chemoembolization of hepatocellular carcinoma using miriplatin, a lipophilic anticancer drug: Short-term results

Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter

Balloon-occluded transarterial chemoembolization using a 1.8-French tip Coaxial microballoon catheter for hepatocellular carcinoma: Technical and safety considerations

Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter

Dense Accumulation of Lipiodol Emulsion in Hepatocellular Carcinoma Nodule during Selective Balloon-occluded Transarterial Chemoembolization: Measurement of Balloon- occluded Arterial Stump Pressure

Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter

Safety and efficacy of balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma

Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter

Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma

Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter

A review discussing the use of polyethylene glycol microspheres in the treatment of hepatocellular carcinoma

Featured product: LifePearl™ Drug Elutable Microspheres

Balloon-occluded transarterial chemoembolization using a 1.8-French tip Coaxial micro balloon catheter for hepatocellular carcinoma: Technical and safety considerations

Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter

Balloon-Occluded DEB-TACE for a single node HCC as bridge to transplantation

Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter

Successful Balloon-Occluded DEB-TACE after failure of SIRT and DEB-TACE

Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter

SIRT with Occlusafe in unresectable HCC, portal vein thrombosis and high-flow fistula

Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter

Y90 SIRT with Occlusafe® Micro-Balloon Catheter infusion system in a patient with unresectable HCC: the right way

Featured product: Occlusafe™ Temporary Occlusion Balloon Microcatheter

LifePearl® loaded with doxorubicin - downstage a patient with HCC to reach liver transplant

Featured product: LifePearl™ Drug Elutable Microspheres

Lifepearl loaded with doxorubicin in a patient with HCC pre-transplant

Featured product: LifePearl™ Drug Elutable Microspheres

See all clinical evidence

Do you need more info about this product?

Our sales representatives are here for you.

Contact us
Send us a message
I have read and accept Terumo Privacy And Cookies Policy and the Terms Of Use*
I wish to receive information and marketing updates from Terumo.
* mandatory fields

Thank you for contacting us!

We typically respond within 2 business days and will come back to you as soon as possible.

Are you a healthcare professional?

This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public


For Pharmaceutical Professionals interested in our B2B products portfolio, please visit Terumo Pharmaceutical Solutions.